YK Bioventures Opportunities GP I, LLC's Form 4 filing
Cero Therapeutics Holdings, Inc. (CERO) · filed Nov 14, 2024
- Accession no.
- 0001415889-24-026908
- Filed
- Nov 14, 2024, 8:14 PM ET
- Trade date
- Oct 10, 2024
- Filing delay
- 35 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $325.0K. It was filed 35 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| YK Bioventures Opportunities GP I, LLCCIK 0002042634 | 10% Owner |
| YK Bioventures Opportunities Fund I, L.P.CIK 0002042636 | 10% Owner |
| Kossar Mitchell WilliamCIK 0002042691 | 10% Owner |
| Yeung Gary KahingCIK 0002042700 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2024 | Common Stock | SSaleDisposed | −3,250,000 | $0.10 | −$325,000 | 22,620,783 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.